The Rheumatologist
COVID-19 NewsACR Convergence
  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed
  • Home
  • Conditions
    • Rheumatoid Arthritis
    • SLE (Lupus)
    • Crystal Arthritis
      • Gout Resource Center
    • Spondyloarthritis
    • Osteoarthritis
    • Soft Tissue Pain
    • Scleroderma
    • Vasculitis
    • Systemic Inflammatory Syndromes
    • Guidelines
  • Resource Centers
    • Axial Spondyloarthritis Resource Center
    • Gout Resource Center
    • Psoriatic Arthritis Resource Center
    • Rheumatoid Arthritis Resource Center
    • Systemic Lupus Erythematosus Resource Center
  • Drug Updates
    • Biologics & Biosimilars
    • DMARDs & Immunosuppressives
    • Topical Drugs
    • Analgesics
    • Safety
    • Pharma Co. News
  • Professional Topics
    • Ethics
    • Legal
    • Legislation & Advocacy
    • Career Development
      • Certification
      • Education & Training
    • Awards
    • Profiles
    • President’s Perspective
    • Rheuminations
    • Interprofessional Perspective
  • Practice Management
    • Billing/Coding
    • Quality Assurance/Improvement
    • Workforce
    • Facility
    • Patient Perspective
    • Electronic Health Records
    • Apps
    • Information Technology
    • From the College
    • Multimedia
      • Audio
      • Video
  • Resources
    • Issue Archives
    • ACR Convergence
      • Gout Resource Center
      • Axial Spondyloarthritis Resource Center
      • Psoriatic Arthritis
      • Abstracts
      • Meeting Reports
      • ACR Convergence Home
    • American College of Rheumatology
    • ACR ExamRheum
    • Research Reviews
    • ACR Journals
      • Arthritis & Rheumatology
      • Arthritis Care & Research
      • ACR Open Rheumatology
    • Rheumatology Image Library
    • Treatment Guidelines
    • Rheumatology Research Foundation
    • Events
  • About Us
    • Mission/Vision
    • Meet the Authors
    • Meet the Editors
    • Contribute to The Rheumatologist
    • Subscription
    • Contact
  • Advertise
  • Search
You are here: Home / Articles / Psoriatic Arthritis: Recognize, Manage Comorbidities

Psoriatic Arthritis: Recognize, Manage Comorbidities

May 15, 2015 • By Karen Appold

  • Tweet
  • Email
Print-Friendly Version / Save PDF
MariesImages/shutterstock.com

Image Credit: MariesImages/shutterstock.com

As the literature on comorbidities linked to psoriatic arthritis (PsA) expands, it’s becoming more difficult for clinicians to keep up with what comorbidities should be assessed and how these comorbidities affect treatment selection. Given this, rheumatologists at the Perelman School of Medicine at University of Pennsylvania, Cleveland Clinic and Hospital for Special Surgery in New York set out to provide an update that could be applied in clinical practice. Their findings were recently published in Current Opinion in Rheumatology.

You Might Also Like
  • 2015 Treatment Recommendation Updates for Psoriatic Arthritis Address Comorbidities, New Medications
  • 2015 Treatment Recommendations for Psoriatic Arthritis
  • New Guideline for the Treatment of Psoriatic Arthritis
Explore This Issue
May 2015
Also By This Author
  • What Makes an Effective Department Head?

Leading author Alexis Ogdie-Beatty, MD, Division of Rheumatology, Center for Clinical Epidemiology and Biostatistics, Center for Pharmacoepidemiology Research and Training, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, says it is important to focus on the entire clinical picture when treating patients with PsA because the condition is not just a disease of the joints and skin. “Comorbidities need to be considered in order to provide the patient with the best care possible,” she says.

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

According to the review, “over half of patients with PsA have more than one comorbidity; this has a significant impact on quality of life.”1

Dr. Ogdie- Beatty

Dr. Ogdie-Beatty

Commenting on the review, Eric M. Ruderman, MD, professor of medicine, Division of Rheumatology, Northwestern University Feinberg School of Medicine, Chicago, says, “Focusing treatment on only a single aspect of the associated disease spectrum risks ignoring issues that may have significant impact on patient function and, worse, may lead to potentially avoidable long-term negative outcomes.”

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

This doesn’t mean that if a patient is diagnosed with PsA that he or she should be immediately screened for comorbidities, however. “Sometimes the first visit with a patient who is just being diagnosed with PsA is already overwhelming with the workup for inflammatory arthritis, the discussion about potential therapies and the screening tests needed for therapies,” Dr. Ogdie-Beatty says. “A thorough history and review of systems should be performed for all patients, and then—once the dust settles from the initial diagnosis—screening measures for comorbidities should be performed.”

Patients may not realize that there can be a relationship between PsA & eye disease.

Dr. Husni

Dr. Husni

Co-author M. Elaine Husni, MD, MPH, vice chair, Cleveland Clinic Arthritis and Musculoskeletal Treatment Center, Orthopaedic and Rheumatologic Institute, agrees. “You first want to get their disease under good control. Then subsequent visits can focus on screening for comorbidities.” Rheumatologists may prefer to administer this process, given their training in internal medicine, or they may refer the patient to different specialists for testing.

ad goes here:advert-3
ADVERTISEMENT
SCROLL TO CONTINUE

Pages: 1 2 3 | Single Page

Filed Under: Conditions, Systemic Inflammatory Syndromes Tagged With: comorbidities, patient care, Psoriatic Arthritis, rheumatologistIssue: May 2015

You Might Also Like:
  • 2015 Treatment Recommendation Updates for Psoriatic Arthritis Address Comorbidities, New Medications
  • 2015 Treatment Recommendations for Psoriatic Arthritis
  • New Guideline for the Treatment of Psoriatic Arthritis
  • From the Front Lines: Managing RA Comorbidities in Primary Care

ACR Convergence

Don’t miss rheumatology’s premier scientific meeting for anyone involved in research or the delivery of rheumatologic care or services.

Visit the ACR Convergence site »

Simple Tasks

Learn more about the ACR’s public awareness campaign and how you can get involved. Help increase visibility of rheumatic diseases and decrease the number of people left untreated.

Visit the Simple Tasks site »

American College of Rheumatology

Visit the official website for the American College of Rheumatology.

Visit the ACR »

The Rheumatologist newsmagazine reports on issues and trends in the management and treatment of rheumatic diseases. The Rheumatologist reaches 11,500 rheumatologists, internists, orthopedic surgeons, nurse practitioners, physician assistants, nurses, and other healthcare professionals who practice, research, or teach in the field of rheumatology.

About Us / Contact Us / Advertise / Privacy Policy / Terms of Use / Cookie Preferences

  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed

Copyright © 2006–2023 American College of Rheumatology. All rights reserved.

ISSN 1931-3268 (print)
ISSN 1931-3209 (online)